Jiangsu Hengrui Medicine Co., Ltd.
Clinical trials sponsored by Jiangsu Hengrui Medicine Co., Ltd., explained in plain language.
Pharmaceutical company developing innovative drugs in oncology, anesthesia, and more.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a new pill tame ulcerative colitis?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral medication called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goal is to see if the drug is safe and tolerable, and to understand how it moves through the body…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new drug improve muscle relaxation during surgery?
Disease control Not yet recruitingThis trial tests whether an experimental drug called HRS-9190 can safely and effectively relax muscles during general anesthesia for elective surgery. It compares HRS-9190 to a standard muscle relaxant, rocuronium, in about 320 adults. The study measures how well the drug enables…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Healthy volunteers to test new formulation of breast cancer drug HRS-6209
Knowledge-focused Not yet recruitingThis early-stage trial will test two different versions of the experimental drug HRS-6209 in 21 healthy Chinese adults. The goal is to see how the body absorbs the old and new capsule forms, and whether a high-fat meal affects absorption. No treatment benefit is expected for part…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC